|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/569 |
| (11) | Patento numeris | 2972368 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14712628.8 |
| Europos patento paraiškos padavimo data | 2014-03-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/055282 |
| Data | 2014-03-17 |
| (87) | Numeris | WO 2014/140362 |
| Data | 2014-09-18 |
| (30) | Numeris | Data | Šalis |
| 13382091 | 2013-03-15 | EP |
| (72) |
DE LA ROSA, Olga, ES
LOMBARDO, Eleuterio, ES
DALEMANS, Wilfried, BE
|
| (73) |
TiGenix, S.A.U.,
Parque Tecnol gico de Madrid C/ Marconi, 1, 28760 Tres Cantos (Madrid),
ES
TIGENIX N.V., Haarsrode Research Park 1724 Romeinse straat 12 bus 2, 3001 Leuven, BE |
| (54) | LYMPHOCYTE BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY |
| LYMPHOCYTE BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY |